Clinical trial
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid…
NCT00019331 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019331 |
|---|---|
| Title | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors |
| Official title | Vaccine Therapy With Tumor Specific Mutated Ras Peptides and IL-2 or GM-CSF for Adult Patients With Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Endometrial Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Melanoma (Skin), Pancreatic Cancer, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug |
| Interventions | aldesleukin, ras peptide cancer vaccine, sargramostim, DetoxPC |
| Start date | Oct 1, 1997 |
| Completion | May 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: